An Investigation of the Availability of CYFRA21-1 as a Tumor Marker in Head and Neck Cancer.

Practica Otologica - Japan
doi 10.5631/jibirin.90.1305
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Society of Practical Otolaryngology

Related search

Head and Neck Cancer: Table 1

Cancer Research
Cancer ResearchOncology
2004English

hTERT Promoter Methylation Status in Peripheral Blood Leukocytes as a Molecular Marker of Head and Neck Cancer Progression

Journal of Applied Genetics
MedicineGenetics
2018English

Salivary Soluble CD44: A Potential Molecular Marker for Head and Neck Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Postradiation Metabolic Tumor Volume Predicts Outcome in Head-And-Neck Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2011English

Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

Surgical Neuroangiography of Head and Neck Tumor

Japanese jornal of Head and Neck Cancer
1989English

Chronologic Aging Decreases Tumor Angiogenesis and Metastasis in a Mouse Model of Head and Neck Cancer

International Journal of Oncology
Cancer ResearchOncology
2010English

Head and Neck Cancer

Journal of Oncology
Oncology
2009English

Clinical Impact of CYFRA 21 – 1 as a Tumor Marker for Regional and Distant Tumor Control in Advanced Oropharyngeal Cancer

2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy